IPO Boutique

Merrimack Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Merrimack Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Merrimack PharmaceuticalsMACK -
NASDAQ
$8.00-$10.00 $7.00 $7.0014.3 million3/29/2012
J.P. Morgan, BofA Merrill Lynch
Co-Manager(s):
Cowen and Company, Oppenheimer & Co.
Health Care
Filing(s):




Merrimack Pharmaceuticals Quote & Chart - Click for current quote - MACK

About Merrimack Pharmaceuticals (adapted from Merrimack Pharmaceuticals prospectus):
They are a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines consisting of novel therapeutics paired with companion diagnostics.

This description is adapted from Merrimack prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Merrimack "MACK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved